GS-EU-337-1820 - An Observational Drug Utilization Study of Ledipasvir/Sofosbuvir and Tenofovir Disoproxil Fumarate + Pharmacokinetic Enhancer Co-Administration in Adults Co-Infected with Chronic Hepatitis C and HIV-1 Infections (HAVEN co-infection study) | HMA-EMA Catalogues of real-world data sources and studies

Study protocol

Initial protocol

GS-EU-337-1820 Original Protocol 16 March 2016 FINAL

English (600.49 KB - PDF) View document

Study results

GS-EU-337-1820 Annual Progress Report

English (1.31 MB - PDF) View document

Study report

GS-EU-337-1820 Interim Progress Report

English (1.27 MB - PDF) View document

Other information

GS-EU-337-1820 - An Observational Drug Utilization Study of Ledipasvir/Sofosbuvir and Tenofovir Disoproxil Fumarate + Pharmacokinetic Enhancer Co-Administration in Adults Co-Infected with Chronic Hepatitis C and HIV-1 Infections (HAVEN co-infection study)